The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued its final resolution in a 2025 case following a voluntary admission by Pfizer, concluding that the company failed to maintain high standards, certify required materials, and ensure appropriate hospitality.
The PMCPA case identifies multiple breaches of the Association of the British Pharmaceutical Industry’s